RXRX files Form 144 to sell 7,956 Class A shares

RXRX submitted a Form 144 reporting the proposed sale of 7,956 Class A shares tied to restricted stock vesting on 03/15/2026.

Rhea-AI Filing Summary

RXRX submitted a Form 144 reporting the proposed sale of 7,956 Class A shares tied to restricted stock vesting on 03/15/2026. The filing lists prior dispositions by Ben Taylor of 21,383 Class A shares on 12/29/2025 and 13,426 Class A shares on 02/18/2026. The broker listed is Fidelity Brokerage Services LLC.

Insights

Securities Counsel

Form 144 notifies market of a planned restricted‑stock sale following vesting.

Form 144 records a proposed sale of 7,956 Class A shares by reason of Restricted Stock Vesting on 03/15/2026. The filing names Fidelity Brokerage Services LLC as broker/agent.

Reported prior dispositions by Ben Taylor (21,383 and 13,426 shares) appear as recent secondary sales; timing and cash‑flow treatment are limited to the stated dates and amounts.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does RXRX's Form 144 report?

Form 144 reports a proposed sale of 7,956 Class A shares tied to restricted stock vesting on 03/15/2026. It also lists prior sales by Ben Taylor of 21,383 and 13,426 Class A shares on the stated dates.

Who is the broker handling the RXRX sale listed on Form 144?

The filing lists Fidelity Brokerage Services LLC as the broker/agent associated with the securities. The entry includes an address line and indicates the transaction type is a brokered disposition tied to the vesting event.

Were there recent RXRX insider or related-party sales disclosed?

Yes. The filing shows Ben Taylor sold 21,383 Class A shares on 12/29/2025 and 13,426 Class A shares on 02/18/2026. These amounts are reported in the "Securities Sold During The Past 3 Months" section.

What is the reason given for the 7,956 share sale in the RXRX Form 144?

The stated reason for the 7,956 Class A shares sale is Restricted Stock Vesting, with the issuer listed as the source and an effective date of 03/15/2026 for the vesting event.

Does the Form 144 state who receives proceeds from the RXRX sale?

The excerpt ties the 7,956 shares to Issuer compensation vesting, but it does not detail cash‑flow recipients or proceeds handling beyond listing the issuer and broker in the provided lines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 10:53 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001712276
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RECURSION PHARMACEUTICALS, INC.
SEC File Number	001-40323
Address of Issuer	41S RIO GRANDE STREET SALT LAKE CITY UTAH 84101
Phone	(385) 269-0203
Name of Person for Whose Account the Securities are To Be Sold	Taylor Ben R
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7956	26970.84	521950663	03/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	03/15/2026	Restricted Stock Vesting	Issuer			7956	03/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ben Taylor 41 S Rio Grande Street Salt Lake City UT 84101	Class A	12/29/2025	21383	89380.94
Ben Taylor 41 S Rio Grande Street Salt Lake City UT 84101	Class A	02/18/2026	13426	41352.08

144: Remarks and Signature

Remarks
Date of Notice	03/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Ben Taylor
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)